Cover Page
Item 1. Business
Overview
The United States Clinical Laboratory Testing Market
Corporate Strategy and Growth Opportunities
Our Services
Routine Testing
Esoteric Testing
New Test Introductions
Clinical Trials Testing
Other Services and Products
Payers and Customers
Sales and Marketing
Information Systems
Billing
Competition
Quality Assurance
Regulation of Clinical Laboratory Operations
Healthcare Information Technology
Privacy and Security of Health Information; Standard Transactions
Regulation of Reimbursement for Clinical Laboratory Services
Government Investigations and Related Claims
Compliance Program
Intellectual Property Rights
Insurance
Employees
Cautionary Statement For Purposes Of The “Safe Harbor” Provisions
Of The Private Securities Litigation Reform Act Of 1995
Item 2. Properties
Item 3. Legal Proceedings
Item 4. Submission of Matters to a Vote of Security Holders
Item 5. Market for Registrant’s Common Stock, Related Stockholder Matters
and Issuer Purchases of Equity Securities
Item 6. Selected Financial Data
Item 7. Management’s Discussion and Analysis of Financial Condition and
Results of Operations
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Item 8. Financial Statements and Supplementary Data
Item 9. Changes in and Disagreements with Accountants on Accounting
and Financial Disclosure
Item 9A. Controls and Procedures
Item 9B. Other Information
Item 10. Directors and Executive Officers of the Registrant
Item 11. Executive Compensation
Item 12. Security Ownership of Certain Beneficial Owners and Management
Item 13. Certain Relationships and Related Transactions
Item 14. Principal Accounting Fees and Services
Item 15. Exhibits, Financial Statement Schedules
Selected Historical Financial Data of Our Company
Management’s Discussion and Analysis of Financial Condition
and Results of Operations
Report of Management on Internal Control Over Financial Reporting
Report of Independent Registered Public Accounting Firm
Consolidated Financial Statements and Related Notes
Supplementary Data: Quarterly Operating Results (unaudited)
Schedule II—Valuation Accounts and Reserves
Reconciliation of Non-GAAP Measures
Return to Narrative
